Download - RT Technique in Cervical Cancer
![Page 1: RT Technique in Cervical Cancer](https://reader038.vdocuments.net/reader038/viewer/2022102922/5476ddcab4af9f15388b4718/html5/thumbnails/1.jpg)
CERVICAL CANCERRT Technique
Mr.Kiattisak Promsensa
![Page 2: RT Technique in Cervical Cancer](https://reader038.vdocuments.net/reader038/viewer/2022102922/5476ddcab4af9f15388b4718/html5/thumbnails/2.jpg)
Introduction• Cervical cancer constitutes 6% of all
female cancers in the USA. • responsible for 1.6% of all cancer-related
mortality• 15% of all gynecologic cancer mortalities
in women • most common gynecological cancer in
developing and underdeveloped countries.
![Page 3: RT Technique in Cervical Cancer](https://reader038.vdocuments.net/reader038/viewer/2022102922/5476ddcab4af9f15388b4718/html5/thumbnails/3.jpg)
CA Cervix in Thailand• leading cancers in Thailand for female
population• seven women die from cervical cancer
each day• most common stage is stage I• most common histologic type was
squamous cell carcinoma, followed by adenocarcinoma
Sarikapan Wilailak, J Gynecol Oncol. 2009 June; 20(2): 81–83
![Page 4: RT Technique in Cervical Cancer](https://reader038.vdocuments.net/reader038/viewer/2022102922/5476ddcab4af9f15388b4718/html5/thumbnails/4.jpg)
Anatomy of the female genital tract
![Page 5: RT Technique in Cervical Cancer](https://reader038.vdocuments.net/reader038/viewer/2022102922/5476ddcab4af9f15388b4718/html5/thumbnails/5.jpg)
![Page 6: RT Technique in Cervical Cancer](https://reader038.vdocuments.net/reader038/viewer/2022102922/5476ddcab4af9f15388b4718/html5/thumbnails/6.jpg)
1. paracervical2. parametrial3. internal iliac4. external iliac5. common iliac6. presacral
![Page 7: RT Technique in Cervical Cancer](https://reader038.vdocuments.net/reader038/viewer/2022102922/5476ddcab4af9f15388b4718/html5/thumbnails/7.jpg)
Pathology
• Squamous cell carcinomamost common, ≈ 80%
• Adenocarcinoma, ≈ 15%
• Others
![Page 8: RT Technique in Cervical Cancer](https://reader038.vdocuments.net/reader038/viewer/2022102922/5476ddcab4af9f15388b4718/html5/thumbnails/8.jpg)
Robb
ins
and
Cotr
an P
atho
logi
c Ba
sis
of D
isea
se 7
ed
![Page 9: RT Technique in Cervical Cancer](https://reader038.vdocuments.net/reader038/viewer/2022102922/5476ddcab4af9f15388b4718/html5/thumbnails/9.jpg)
Clinical characteristic of the cancer• exophytic or fungating• infiltrative• ulcerative
![Page 10: RT Technique in Cervical Cancer](https://reader038.vdocuments.net/reader038/viewer/2022102922/5476ddcab4af9f15388b4718/html5/thumbnails/10.jpg)
แนวทางเวชปฏิ�บั ติ� การติรวจคั ดกรองมะเร�งปากมดลู�ก แลูะการร กษาผู้��ป�วยท� ม�คัวามผู้�ดปกติ�ของปากมดลู�ก สำ#าน กพั ฒนาว�ชาการแพัทย& กรมการแพัทย& กระทรวงสำาธารณสำ)ข
![Page 11: RT Technique in Cervical Cancer](https://reader038.vdocuments.net/reader038/viewer/2022102922/5476ddcab4af9f15388b4718/html5/thumbnails/11.jpg)
Risk factors• early first intercourse• multiple partners• history of other STD’s• A male partner with multiple previous
sexual partners• high parity• smoking• immunosuppression• The presence of a cancer-associated
HPV(type 16, 18)
![Page 12: RT Technique in Cervical Cancer](https://reader038.vdocuments.net/reader038/viewer/2022102922/5476ddcab4af9f15388b4718/html5/thumbnails/12.jpg)
Clinical PresentationEarly• Postcoital bleeding• Irregular menstruation• Bloody discharge• Discharge with foul odor• Leg and groin painLate• Fistulas (cervicovesical, vesicovaginal,
cervicorectal, rectovaginal)• Hydronephrosis and renal dysfunction due to
ureter obstruction• Edema in lower extremities• Anemia
![Page 13: RT Technique in Cervical Cancer](https://reader038.vdocuments.net/reader038/viewer/2022102922/5476ddcab4af9f15388b4718/html5/thumbnails/13.jpg)
Screening for cervical cancer
• Screening with Pap smear decreases mortality by 70%
• ACS recommends screening for all women who are sexually active or >20 years old
• three normal annual exams after age 30• at least once every 3 years
![Page 14: RT Technique in Cervical Cancer](https://reader038.vdocuments.net/reader038/viewer/2022102922/5476ddcab4af9f15388b4718/html5/thumbnails/14.jpg)
Robbins and Cotran Pathologic Basis of Disease 7ed
![Page 15: RT Technique in Cervical Cancer](https://reader038.vdocuments.net/reader038/viewer/2022102922/5476ddcab4af9f15388b4718/html5/thumbnails/15.jpg)
Initial evaluation• complete history and physical examination• colposcopy ± conization/biopsy• full pelvic exam• cysto+proctoscopy• Laboratories: CBC, LFTs, chemistries, BUN/Cr,
urinalysis• CXR, IVP• If stage IIIB, place renal stent prior to starting
chemo
![Page 16: RT Technique in Cervical Cancer](https://reader038.vdocuments.net/reader038/viewer/2022102922/5476ddcab4af9f15388b4718/html5/thumbnails/16.jpg)
Staging (FIGO 2008)
• Stage I. Carcinoma strictly confined to the cervix; extension to the uterine corpus should be disregarded– IA : Microscopically• IA1 : depth ≤ 3 mm., diameter ≤ 7 mm.• IA2 : depth >3 – 5 mm., diameter ≤ 7 mm.
– IB : clinical visible or greater than IA2• IB1 : visible ≤ 4 cm.• IB2 : visible > 4 cm.
![Page 17: RT Technique in Cervical Cancer](https://reader038.vdocuments.net/reader038/viewer/2022102922/5476ddcab4af9f15388b4718/html5/thumbnails/17.jpg)
• Stage II. extends beyond the cervix but has not extended onto the pelvic wall, involves the vagina < lower 1/3– IIA : No parametrium involvement,
upper 2/3 of vagina– IIB : With parametrium involvement
< pelvic sidewall
![Page 18: RT Technique in Cervical Cancer](https://reader038.vdocuments.net/reader038/viewer/2022102922/5476ddcab4af9f15388b4718/html5/thumbnails/18.jpg)
• Stage III. extended onto the pelvic sidewall and/or involves the lower 1/3 of the vagina, involve pelvic sidewall, hydronephrosis or nonfunctioning kidney– IIIA : No pelvic sidewall involvement,
lower 1/3 of vagina– IIIB : Extension to pelvic sidewall,
hydronephrosis or nonfunctioning kidney or regional lymph node metastasis
![Page 19: RT Technique in Cervical Cancer](https://reader038.vdocuments.net/reader038/viewer/2022102922/5476ddcab4af9f15388b4718/html5/thumbnails/19.jpg)
• Stage IV. extended beyond the true pelvis or has clinically involved the mucosa of the bladder and/or rectum– IVA : spread onto adjacent pelvic organs– IVB : spread to distant organs
![Page 20: RT Technique in Cervical Cancer](https://reader038.vdocuments.net/reader038/viewer/2022102922/5476ddcab4af9f15388b4718/html5/thumbnails/20.jpg)
![Page 21: RT Technique in Cervical Cancer](https://reader038.vdocuments.net/reader038/viewer/2022102922/5476ddcab4af9f15388b4718/html5/thumbnails/21.jpg)
![Page 22: RT Technique in Cervical Cancer](https://reader038.vdocuments.net/reader038/viewer/2022102922/5476ddcab4af9f15388b4718/html5/thumbnails/22.jpg)
Recommended Treatment
Preinvasive• Conization or loop electrosurgical
excisional procedure (LEEP) or laser or cryotherapy ablation or simple hysterectomy
![Page 23: RT Technique in Cervical Cancer](https://reader038.vdocuments.net/reader038/viewer/2022102922/5476ddcab4af9f15388b4718/html5/thumbnails/23.jpg)
Stage IA• Total abdominal hysterectomy or
trachelectomy or large cone biopsy with negative margins and close follow-up (if fertility preservation desired). Radical hysterectomy preferred for IA2 lesions
OR• Brachytherapy alone (LDR 65–75 Gy
or HDR 7 Gy × 5–6 fx). If high-risk pathologic features, treat as IB
![Page 24: RT Technique in Cervical Cancer](https://reader038.vdocuments.net/reader038/viewer/2022102922/5476ddcab4af9f15388b4718/html5/thumbnails/24.jpg)
Stage IB1• Radical hysterectomy with pelvic LN
dissectionOR• Definitive RT: EBRT to WP (45 Gy)
and brachytherapy (HDR 6 Gy × 5 fx, 7 Gy × 4 fx or LDR 15–20 Gy × 2 fx)
![Page 25: RT Technique in Cervical Cancer](https://reader038.vdocuments.net/reader038/viewer/2022102922/5476ddcab4af9f15388b4718/html5/thumbnails/25.jpg)
Stage IB2 - IIA• Concurrent chemo-RT with cisplatin.
WP RT (45 Gy). Brachytherapy = HDR 6 Gy × 5 fx, 7 Gy × 4 fx or LDR 15–20 Gy × 2 fx
![Page 26: RT Technique in Cervical Cancer](https://reader038.vdocuments.net/reader038/viewer/2022102922/5476ddcab4af9f15388b4718/html5/thumbnails/26.jpg)
Stage IIB• Concurrent chemo-RT with cisplatin.
WP RT (45–50.4 Gy). Brachytherapy = HDR 6 Gy × 5 fx, 7 Gy × 4 fx or LDR 15–20 Gy × 2 fx
![Page 27: RT Technique in Cervical Cancer](https://reader038.vdocuments.net/reader038/viewer/2022102922/5476ddcab4af9f15388b4718/html5/thumbnails/27.jpg)
Stage IIIA• Concurrent chemo-RT with cisplatin.
RT to WP, vagina, and inguinal LN (45 Gy-50.4 Gy). Brachytherapy = HDR 6 Gy × 5 fx, 7 Gy × 4 fx or LDR 17–20 Gy × 2 fx
![Page 28: RT Technique in Cervical Cancer](https://reader038.vdocuments.net/reader038/viewer/2022102922/5476ddcab4af9f15388b4718/html5/thumbnails/28.jpg)
Stage IIIB - IVA• Concurrent chemo-RT with cisplatin.
WP RT (50–54 Gy). Brachytherapy = HDR 6 Gy × 5, 7 Gy × 4 fx or LDR 20 Gy × 2. If LN+, add paraaortic LN IMRT (45–60 Gy)
Stage IVB• Combination chemotherapy
![Page 29: RT Technique in Cervical Cancer](https://reader038.vdocuments.net/reader038/viewer/2022102922/5476ddcab4af9f15388b4718/html5/thumbnails/29.jpg)
Indication for post-op RT
• Lymphovascular space invasion (LVSI)• Deep stromal invasion > one-third of
stromal depth• Tumor size > 4 cm• Adenosquamous, clear cell, small cell,
undifferentiated histology
![Page 30: RT Technique in Cervical Cancer](https://reader038.vdocuments.net/reader038/viewer/2022102922/5476ddcab4af9f15388b4718/html5/thumbnails/30.jpg)
Indication for post-op Chemo + RT• Surgical margin (+)• LN (+)• Parametrial involvement
![Page 31: RT Technique in Cervical Cancer](https://reader038.vdocuments.net/reader038/viewer/2022102922/5476ddcab4af9f15388b4718/html5/thumbnails/31.jpg)
![Page 32: RT Technique in Cervical Cancer](https://reader038.vdocuments.net/reader038/viewer/2022102922/5476ddcab4af9f15388b4718/html5/thumbnails/32.jpg)
Five-year survival in FIGO stage IB cervical cancer according to surgery or radiotherapy
![Page 33: RT Technique in Cervical Cancer](https://reader038.vdocuments.net/reader038/viewer/2022102922/5476ddcab4af9f15388b4718/html5/thumbnails/33.jpg)
EBRT
• CT-based planning is recommended• Intensity-modulated radiation
therapy (IMRT) should be considered experimental
![Page 34: RT Technique in Cervical Cancer](https://reader038.vdocuments.net/reader038/viewer/2022102922/5476ddcab4af9f15388b4718/html5/thumbnails/34.jpg)
Beam Energy and Dose Calculation• A megavoltage accelerator with a minimum source
to an isocenter distance of 100 cm is recommended.
• Higher energy photons beams, 10–18 MV, should be used if possible to reduce the dose to normal tissue.
• Doses are to be calculated without heterogeneity correction, i.e., no correction is to be made for density differences between air in the bowel and fluid in the bladder.
• Four fields should be used for maximal sparing of normal tissue (especially small bowel and sciatic nerve).
![Page 35: RT Technique in Cervical Cancer](https://reader038.vdocuments.net/reader038/viewer/2022102922/5476ddcab4af9f15388b4718/html5/thumbnails/35.jpg)
FieldAnterior–posterior fields• Superior : L4–L5 intervertebral
space• Inferior : below the obturator
foramens (vagina (−)) or ischial tuberosities (vagina (+))
• Lateral : bony pelvis +1.5–2 cm
![Page 36: RT Technique in Cervical Cancer](https://reader038.vdocuments.net/reader038/viewer/2022102922/5476ddcab4af9f15388b4718/html5/thumbnails/36.jpg)
Lateral fields• Superior and inferior: same as
anterior–posterior fields.• Anterior: posterior to pubis.• Posterior: between the S2 and
S3 vertebrae (midsacrum); maximum care should be given to posterior extension of tumor, and a margin of at least 1–2 cm should be given to the tumor.
![Page 37: RT Technique in Cervical Cancer](https://reader038.vdocuments.net/reader038/viewer/2022102922/5476ddcab4af9f15388b4718/html5/thumbnails/37.jpg)
![Page 38: RT Technique in Cervical Cancer](https://reader038.vdocuments.net/reader038/viewer/2022102922/5476ddcab4af9f15388b4718/html5/thumbnails/38.jpg)
Parametrial Boost field• indicated in patients with bulky primary disease.
An additional dose of 5.4–9.0 Gy can be considered for parametrial
• The superior border : 1 cm superior to the bottom of the SI joint.
• The lateral and inferior borders : are identical to the AP/PA field of the whole pelvic setting.
• A midline block of 4–5 cm in diameter blocks bladder and rectum hotspots from brachytherapy. A customized midline shielding can be contoured using a point A isodose line and is associated with fewer complications
![Page 39: RT Technique in Cervical Cancer](https://reader038.vdocuments.net/reader038/viewer/2022102922/5476ddcab4af9f15388b4718/html5/thumbnails/39.jpg)
• Paraaortic LN (+); paraaortic field should be irradiated
• Prophylactic paraaortic field is not recommended since it has no effect on survival. It also decreases the tolerance of radiotherapy by increasing toxicity
Paraaortic field
![Page 40: RT Technique in Cervical Cancer](https://reader038.vdocuments.net/reader038/viewer/2022102922/5476ddcab4af9f15388b4718/html5/thumbnails/40.jpg)
Paraaortic fieldAP/PA fields– superior border : T11 and T12 interspace– inferior border : L4–5 interspace (if separating
from pelvic fields) or continues with the AP/PA fields of the pelvic portal
– lateral border : lateral aspects of transverse processes
Lateral fields– anterior border : 2 cm anterior to vertebral
bodies– posterior border : should split the vertebral
bodies
![Page 41: RT Technique in Cervical Cancer](https://reader038.vdocuments.net/reader038/viewer/2022102922/5476ddcab4af9f15388b4718/html5/thumbnails/41.jpg)
![Page 42: RT Technique in Cervical Cancer](https://reader038.vdocuments.net/reader038/viewer/2022102922/5476ddcab4af9f15388b4718/html5/thumbnails/42.jpg)
Dose and Fractionation• The whole pelvic field should be treated to 45–50.4
Gy with conventional fractionation (1.8 Gy or 2.0 Gy per fraction)
• If the para-aortic fi eld is added, the para-aortic field should be treated with up to 45 Gy at 1.5–1.8 Gy per fraction
• Parametrial boost should be treated with 5.4–9.0 Gy at 1.8 Gy per fraction
• The approximate average total dose to point A with the LDR brachytherapy implant should deliver 35–45 Gy as described below.
![Page 43: RT Technique in Cervical Cancer](https://reader038.vdocuments.net/reader038/viewer/2022102922/5476ddcab4af9f15388b4718/html5/thumbnails/43.jpg)
Conformal RT Volumes
• CTV = tumor/tumor bed, entire uterus, upper one-third of vagina, parametrium, iliac
• LNs. Paraaortic/common iliac LN (+); paraaortic LN.
• PTV = CTV + 0.5–1 cm.
![Page 44: RT Technique in Cervical Cancer](https://reader038.vdocuments.net/reader038/viewer/2022102922/5476ddcab4af9f15388b4718/html5/thumbnails/44.jpg)
![Page 45: RT Technique in Cervical Cancer](https://reader038.vdocuments.net/reader038/viewer/2022102922/5476ddcab4af9f15388b4718/html5/thumbnails/45.jpg)
Brachytherapy• BT plays a very important role in the
treatment of gynecological cancers, particularly cervical cancers
• Intracavitary and interstitial BT techniques are used in cervical cancers
• For stage IA1 or selected cases of IA2 cervical cancer, intracavitary tandem and ovoid/ring brachytherapy alone can be sufficient treatment
![Page 46: RT Technique in Cervical Cancer](https://reader038.vdocuments.net/reader038/viewer/2022102922/5476ddcab4af9f15388b4718/html5/thumbnails/46.jpg)
Radionuclides used for brachytherapy applications
![Page 47: RT Technique in Cervical Cancer](https://reader038.vdocuments.net/reader038/viewer/2022102922/5476ddcab4af9f15388b4718/html5/thumbnails/47.jpg)
Source Loading Types in Brachytherapy• Manual afterloading: radioactive sources are
applied by long forceps from a certain distance behind a protective barrier. The patient treated with the radioactive sources should be isolated in hospital.
• Remote afterloading: the radioactive source is stored within a shielded computer-controlled machine. The machine has a remote controller, and the radioactive source passes through special tubes and applicators placed inside the patient.
![Page 48: RT Technique in Cervical Cancer](https://reader038.vdocuments.net/reader038/viewer/2022102922/5476ddcab4af9f15388b4718/html5/thumbnails/48.jpg)
ICRU 38• Dose and Volume Specifications for
Reporting Intracavitary Treatments in Gynecologic Malignancies
• Every application of BT should report five major issues1. technique2. total reference air KERMA (TRAK)3. reference volume4. reference points and doses 5. dose rate
![Page 49: RT Technique in Cervical Cancer](https://reader038.vdocuments.net/reader038/viewer/2022102922/5476ddcab4af9f15388b4718/html5/thumbnails/49.jpg)
Technique
• The radioactive source• number and length of sources• the type of applicator
![Page 50: RT Technique in Cervical Cancer](https://reader038.vdocuments.net/reader038/viewer/2022102922/5476ddcab4af9f15388b4718/html5/thumbnails/50.jpg)
Reference air KERMA of source
• KERMA = kinetic energy released in the medium
• the same units as absorbed dose (Gy)• used to define visible activity• defined as the dose given at a distance of
1 m of air by a source with an activity of 1 MBq in 1 h
• Its units are 1 μ/Gy m2 = 1 cGy/h cm2
• Its value is 0.0342 for Ir-192
![Page 51: RT Technique in Cervical Cancer](https://reader038.vdocuments.net/reader038/viewer/2022102922/5476ddcab4af9f15388b4718/html5/thumbnails/51.jpg)
Reference volume
• volume surrounded by the reference isodose• independent of technique• combined volume in the 60 Gy isodose curve of
external pelvic radiotherapy and intracavitary applications
• defined in three planes by combining reference isodoses ; dh: (height), dw: (width), dt: (thickness)
![Page 52: RT Technique in Cervical Cancer](https://reader038.vdocuments.net/reader038/viewer/2022102922/5476ddcab4af9f15388b4718/html5/thumbnails/52.jpg)
![Page 53: RT Technique in Cervical Cancer](https://reader038.vdocuments.net/reader038/viewer/2022102922/5476ddcab4af9f15388b4718/html5/thumbnails/53.jpg)
Reference points
• Bladder reference point• Rectum reference point• Bony reference points; lymphatic
trapezoid (Fletcher trapezoid)• Pelvic wall reference points
![Page 54: RT Technique in Cervical Cancer](https://reader038.vdocuments.net/reader038/viewer/2022102922/5476ddcab4af9f15388b4718/html5/thumbnails/54.jpg)
![Page 55: RT Technique in Cervical Cancer](https://reader038.vdocuments.net/reader038/viewer/2022102922/5476ddcab4af9f15388b4718/html5/thumbnails/55.jpg)
![Page 56: RT Technique in Cervical Cancer](https://reader038.vdocuments.net/reader038/viewer/2022102922/5476ddcab4af9f15388b4718/html5/thumbnails/56.jpg)
![Page 57: RT Technique in Cervical Cancer](https://reader038.vdocuments.net/reader038/viewer/2022102922/5476ddcab4af9f15388b4718/html5/thumbnails/57.jpg)
Dose rate
• the dose given per unit time– low dose rate (LDR), 0.4–2 Gy/h– medium dose rate (MDR), 2–12 Gy/h– high dose rate (HDR), >12 Gy/h
![Page 58: RT Technique in Cervical Cancer](https://reader038.vdocuments.net/reader038/viewer/2022102922/5476ddcab4af9f15388b4718/html5/thumbnails/58.jpg)
The advantages and disadvantages of HDR brachytherapy
![Page 59: RT Technique in Cervical Cancer](https://reader038.vdocuments.net/reader038/viewer/2022102922/5476ddcab4af9f15388b4718/html5/thumbnails/59.jpg)
Dose Prescription Points
• most commonly used ones are points A and B
![Page 60: RT Technique in Cervical Cancer](https://reader038.vdocuments.net/reader038/viewer/2022102922/5476ddcab4af9f15388b4718/html5/thumbnails/60.jpg)
Point A
• defined in the Manchester system2 cm superior to a horizontal line passing from the top of the lateral fornices at the midline and 2 cm lateral from the midline
• It is the point where radiation necrosis is first seen, and uterine artery crosses ureter
• relates to the maximum dose for healthy tissues and the minimum dose for the tumor
![Page 61: RT Technique in Cervical Cancer](https://reader038.vdocuments.net/reader038/viewer/2022102922/5476ddcab4af9f15388b4718/html5/thumbnails/61.jpg)
Point B
• This point is 3 cm lateral to point A• shows the dose taken by the obturator LNs
![Page 62: RT Technique in Cervical Cancer](https://reader038.vdocuments.net/reader038/viewer/2022102922/5476ddcab4af9f15388b4718/html5/thumbnails/62.jpg)
![Page 63: RT Technique in Cervical Cancer](https://reader038.vdocuments.net/reader038/viewer/2022102922/5476ddcab4af9f15388b4718/html5/thumbnails/63.jpg)
Isodose distribution
![Page 64: RT Technique in Cervical Cancer](https://reader038.vdocuments.net/reader038/viewer/2022102922/5476ddcab4af9f15388b4718/html5/thumbnails/64.jpg)
Application of Intracavitary Brachytherapy• the patient should be informed• gynecological exam• lithotomy position• vulva, perineum, and pelvic region are
cleaned• a Foley catheter is placed into the bladder
and its balloon is filled with 7 cc of radioopaque material
• speculum is placed into the vagina, and the cervical os is visualized
![Page 65: RT Technique in Cervical Cancer](https://reader038.vdocuments.net/reader038/viewer/2022102922/5476ddcab4af9f15388b4718/html5/thumbnails/65.jpg)
• metal markers are placed into the cervical os to verify the position of the intrauterine tandem
• the length of the uterine cavity is determined by hysterometry
• the tandem and ovoids are lubricated with 1% viscous lidocaine
• The tandem is first placed into the uterine cavity, and then the ovoids or ring are placed into the fornices and they are all stabilized
• vaginal packing• rectal tube is inserted into the rectum
![Page 66: RT Technique in Cervical Cancer](https://reader038.vdocuments.net/reader038/viewer/2022102922/5476ddcab4af9f15388b4718/html5/thumbnails/66.jpg)
• Dummy catheters are placed into the tandem and ring/or ovoids
• An A–P and a lat. film are taken at the same position
• The dose is prescribed to point A• The source, place and time are optimized in
dosimetry• Applicators are connected to the treatment
machine with special connecting cables• Health personnel move from the treatment
room to the command room and start the BT session
![Page 67: RT Technique in Cervical Cancer](https://reader038.vdocuments.net/reader038/viewer/2022102922/5476ddcab4af9f15388b4718/html5/thumbnails/67.jpg)
Tolerance doses
• Rectum, 75 Gy (mean 68 Gy, <80% of the dose at point A)
• Bladder, 80 Gy (mean 70 Gy, 85% of the dose at point A)
• Vagina, 120–140 Gy (mean 125 Gy)
![Page 68: RT Technique in Cervical Cancer](https://reader038.vdocuments.net/reader038/viewer/2022102922/5476ddcab4af9f15388b4718/html5/thumbnails/68.jpg)
ComplicationsAcute complications• pruritis, dry/moist desquamation• enteritis• proctitis• cystourethritisLate complications• Vaginal stenosis• Vaginal ulceration or necrosis• Late gastrointestinal complications• Ureteral stricture• vesicovaginal or rectovaginal fistula
![Page 69: RT Technique in Cervical Cancer](https://reader038.vdocuments.net/reader038/viewer/2022102922/5476ddcab4af9f15388b4718/html5/thumbnails/69.jpg)
Thank You.
References :• R. Scott Bermudez, Kim Huang, and I-Chow Hsu in Eric K. Hansen (2010). Cervical
Cancer. Handbook of Evidence-Based Radiation Oncology 2nd Edition : (29) 499-511
• Murat Beyzadeoglu, Cuneyt Ebruli, and Gokhan Ozyigit in Murat Beyzadeoglu .Basic Radiation Oncology (2010) . Gynecological Cancers . Cervical Cancer : (9) 411-432
• Subhakar Mutyala and Aaron H. Wolfson in J. J. Lu ・ L. W. Brady (Eds.) (2008) Gynaecological Cancers. Radiation Oncology An Evidence-Based Approach : (24) 358-368